Latest breast cancer News

Enhertu plus pertuzumab approved in the EU as first new regimen in more than a decade for the 1st-line treatment of patients…
A spatially programmable microfluidic chip for multi-stage particle and cell separation
Cancer’s Malignant Remote Control
TGA Approves Update To Indication For TRUQAP
Standard breast cancer classification may overlook important differences
Australia’s projected cancer prevalence is here and why prevention matters more than ever
Westpac announces winners of inaugural Female Founder Awards
Blood-Camouflaged Liquid Metal Nanoparticles Defeat the Most Aggressive Breast Cancer
Doctors brag on Facebook: How to dodge the puberty blocker restrictions
Existing Drug Could Treat Invasive Canine Oral Tumors
Babies born under sugar rationing grew into adults with lower cancer risk
More than 2.6 million Australians projected to be living with or beyond cancer by 2050 
New knowledge could make cancer immunotherapy more effective
Regional differences in chemotherapy treatment for breast cancer may affect survival
Rural cancer patients less likely to get radiotherapy – study
Cells in tumour microenvironment may affect hormone treatment
Scientists identify tumor-secreted protein that promotes lung metastasis in cancer patients
Vivienne named Citizen of the Year at Local Government Week Awards
BreastScreen Australia to support earlier detection and better care
National Stroke Week highlights women’s unique stroke risks
Datroway approved in the EU as only TROP2-directed medicine with overall survival benefit for the 1st-line treatment of patients with metastatic TNBC…
$430 million to power the next generation of Australian health and medical researchers
$430 million for Australian health and medical research investigators
World-renowned breast cancer surgeon shares trial learnings in Brisbane
V8 Supercars Joins Fight Against Prostate Cancer
Enhertu plus pertuzumab recommended for approval in the EU by CHMP as 1st-line treatment for patients with HER2-positive metastatic breast cancer
Helping Cells Find Their Perfect Match
HKUST Develops New Biocompatible Chemical Reaction to Advance Next-Generation Anticancer Prodrugs
Former Wheatbelt local leads charge for cancer research appeal
Time for a clock change? Congress considers daylight saving time … again
How wellness clinics bend the rules to supply unapproved peptides and anti-ageing injections
New data shows progress in cancer outcomes for First Nations people
Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread
Tampons tested for hormone disrupting chemicals
First global breast cancer survival estimates show wide regional and income disparities
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
The hidden risks of grey-market peptides – why women face greater danger
Three clinical scholars appointed to the Ludwig Institute for Cancer Research
Enhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours
Bumper month for cheaper medicines with 10 new PBS listings for July
Datroway recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not…
New South Wales First Dedicated First Nations McGrath Cancer Care Nurse
Jeremy Clarkson has aggressive prostate cancer. But what makes some cancers more aggressive than others?
FOUR QUEENS, ONE LEGENDARY CAUSE
Pharmac Consumer Working Group wraps up, job well done
Community-led projects set to reinvigorate Newcastle Port precinct
World-leading research receives cash boost in Manchester
World’s largest genetic study of ‘moliness’ helps unravel mysteries of melanoma